Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 195 | 585 | 404 | 239 | 358 |
| Cost of Goods | 17 | 69 | 23 | 30 | 35 |
| Gross Profit | 178 | 517 | 381 | 208 | 324 |
| Operating Expenses | 3,129 | 3,378 | 4,263 | 3,839 | 4,395 |
| Operating Income | -2,935 | -2,793 | -3,859 | -3,601 | -4,037 |
| Other Income | 163 | 1 | -1 | 3 | 1 |
| Pre-tax Income | -2,772 | -2,792 | -3,860 | -3,597 | -4,037 |
| Net Income Continuous | -2,772 | -2,792 | -3,860 | -3,597 | -4,037 |
| Net Income | $-2,772 | $-2,792 | $-3,860 | $-3,597 | $-4,037 |
| EPS Basic Total Ops | -0.33 | -0.32 | -0.60 | -0.56 | -0.76 |
| EPS Basic Continuous Ops | -0.33 | -0.32 | -0.60 | -0.56 | -0.76 |
| EPS Diluted Total Ops | -0.33 | -0.32 | -0.60 | -0.56 | -0.76 |
| EPS Diluted Continuous Ops | -0.33 | -0.32 | -0.60 | -0.56 | -0.76 |
| EBITDA(a) | $-2,930 | $-2,789 | $-3,855 | $-3,596 | $-4,034 |